-
Capturing the Realities of Hematological Cancer Patients’ Experiences of Novel Immunotherapies: A Call for Alignment and Action to Improve PROM Within CAR-T and Bispecific Antibody Therapies
Sep 9, 2025, 16:22 PM -
Patterns Of Adoption And Diffusion Of Biological Therapies In Inflammatory Bowel Disease: Patient-Centric Insights From Israel
Sep 9, 2025, 16:22 PM -
Modeling the Anticipated Organizational Impact on Health Service Provision of the Introduction of Tirbanibulin for the Topical Treatment of Actinic Keratosis in France: EPIKA Study
Sep 9, 2025, 16:22 PM -
Health Technology Assessment, Reimbursement, and Funding Landscape Challenges for Oncology Companion Diagnostics in Europe and Canada
Sep 9, 2025, 16:22 PM -
The Effects of Pooling Treatment Effects Targeting Treatment Policy and Hypothetical Estimands With Rank-Preserving Structural Failure Time Model in Oncology Aggregate-Level Meta-Analyses
Sep 9, 2025, 16:22 PM -
Quantifying the Economic Burden of Osteoarthritis in Portugal: Insights From a Patient Journey Model
Sep 9, 2025, 16:22 PM -
Definitive Staging and Perioperative Treatment for Resectable Stage IB-IIIA Non-Small Cell Lung Cancer (NSCLC): A UK Perspective
Sep 9, 2025, 16:22 PM -
Effect of the Inflation Reduction Act on Drug Innovation
Sep 9, 2025, 16:22 PM -
Integrating Environmental Sustainability Into Cost-Effectiveness Analysis and Value Demonstration: A Multidimensional Framework
Sep 9, 2025, 16:22 PM -
Expert Consensus on the Clinical and Economic Value of Advanced Wound-Care Products in Mexico: Results From a Delphi Panel
Sep 9, 2025, 16:22 PM -
Health Technology Assessments of Oncology Orphan and Advanced Therapies: The Case for Incorporating Real-World Evidence Patient-Reported Outcomes and Indirect Treatment Comparisons Into Joint Clinical Assessment Submissions
Sep 9, 2025, 16:22 PM -
Evaluation of Health-Related Quality of Life (HRQoL) Among Patients Treated With Lifileucel After Progression on Immune Checkpoint Inhibitors (ICIs) and Targeted Therapies: Analyses From the C-144-01 Trial
Sep 9, 2025, 16:22 PM -
Decoding Atorvastatin-Induced Arthritis: A Systems Pharmacology Approach Integrating Pharmacovigilance, Bioinformatics, and Pathway Enrichment
Sep 9, 2025, 16:22 PM -
Beyond Leave-One-Out: A Ranked Leave-k-Out Method for Detecting Influential Studies
Sep 9, 2025, 16:22 PM -
Budget Impact of an Organized Cervical Cancer Screening in High-Risk Populations in France
Sep 9, 2025, 16:22 PM -
Exploration of the Utility of Linguistic Validation Cognitive Debriefing Interviews in Generating Evidence for Adding or Modifying Source COA Content
Sep 9, 2025, 16:22 PM -
Transition Across Cognitive States and Death Among Older Adults With Type 2 Diabetes: Determining the Predictors of Cognitive Decline With a Multistate Markov Model
Sep 9, 2025, 16:22 PM -
Are You Implementation Ready? An Alternative Patient And Healthcare System-Centered Model For Pharma
Sep 9, 2025, 16:22 PM -
MIRROR KEYNOTE: Generating Real-World External Control Arms in Non-Small Cell Lung Cancer Using a Curated Database
Sep 9, 2025, 16:22 PM -
Factors Associated With Positive Cost-Effectiveness Judgments in HIRA Drug Reimbursement Decisions: An 8-year Retrospective Review
Sep 9, 2025, 16:22 PM
